More

    Demystifying Blood Clotting in Covid Patients

    Fever, sore throat, dry cough, and shortness of breath are the most common clinical signs of COVID-19. Though asymptomatic instances have also been documented, they are more difficult to detect. As blood clots were discovered in both live and deceased COVID-19 patients, unravelling the mystery is extremely intriguing.

    Parneet Kaur, a research scholar at Shoolini University with the talented team of Saurav Biswas, Azhar Khan, Saurabh Kulshreshtha, and Pardeep Kumar worked on a research hypothesis to simplify the mystery of blood clotting in Covid-19 patients.

    She said, “COVID-19 might trigger your clotting system by causing acute inflammation. While doctors are still studying how COVID-19 targets the body, it appears that a few elements are contributing to the higher risk of clotting.”

    Explaining the mechanism of blood clotting, she said, “It is a two-edged sword. In the case of serious external damage, clotting is critical to avoid blood loss; yet, in the case of an internal injury, clotting is not as important.”

    Further, she explained how the appearance of atypical thrombotic presentations in COVID-19 individuals was a major cause of concern.

    COVID-19 dynamics continue to change as everyday new clinical findings of SARS-CoV-2 pathogenesis emerge, and one such enigma is the creation of inexplicable blood clots in COVID-19 patients’ diverse tissues and organs, which requires immediate care.

    To address this problem, Parneet and her colleagues theorise that the mysterious clots seen in COVID-19 patients are caused by SARS-spike CoV-2’s protein binding to the ACE2 receptor expressed in endothelial cells of blood vessels, causing vasoconstriction and activation of the intrinsic coagulation pathway, which results in blood clot formation.

    Recent Articles

    How To Apply:

    Related Stories

    Leave A Reply

    Please enter your comment!
    Please enter your name here

    Stay on top - Get the daily news in your inbox